JP2007535490A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535490A5
JP2007535490A5 JP2006541588A JP2006541588A JP2007535490A5 JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5 JP 2006541588 A JP2006541588 A JP 2006541588A JP 2006541588 A JP2006541588 A JP 2006541588A JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5
Authority
JP
Japan
Prior art keywords
antibody
monoclonal antibody
another embodiment
group
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541588A
Other languages
English (en)
Japanese (ja)
Other versions
JP4991307B2 (ja
JP2007535490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039071 external-priority patent/WO2005052000A2/en
Publication of JP2007535490A publication Critical patent/JP2007535490A/ja
Publication of JP2007535490A5 publication Critical patent/JP2007535490A5/ja
Application granted granted Critical
Publication of JP4991307B2 publication Critical patent/JP4991307B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541588A 2003-11-21 2004-11-19 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法 Expired - Fee Related JP4991307B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52413103P 2003-11-21 2003-11-21
US60/524,131 2003-11-21
US55585704P 2004-03-24 2004-03-24
US60/555,857 2004-03-24
PCT/US2004/039071 WO2005052000A2 (en) 2003-11-21 2004-11-19 Anti-il-20 antibodies and binding partners and methods of using in inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011212399A Division JP2012036204A (ja) 2003-11-21 2011-09-28 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法

Publications (3)

Publication Number Publication Date
JP2007535490A JP2007535490A (ja) 2007-12-06
JP2007535490A5 true JP2007535490A5 (enExample) 2011-03-03
JP4991307B2 JP4991307B2 (ja) 2012-08-01

Family

ID=34636508

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006541588A Expired - Fee Related JP4991307B2 (ja) 2003-11-21 2004-11-19 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
JP2006541597A Pending JP2007537993A (ja) 2003-11-21 2004-11-19 抗ｉｌ−２０受容体抗体および結合パートナーならびに炎症において用いる方法
JP2011212399A Pending JP2012036204A (ja) 2003-11-21 2011-09-28 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2006541597A Pending JP2007537993A (ja) 2003-11-21 2004-11-19 抗ｉｌ−２０受容体抗体および結合パートナーならびに炎症において用いる方法
JP2011212399A Pending JP2012036204A (ja) 2003-11-21 2011-09-28 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法

Country Status (8)

Country Link
US (3) US20050170468A1 (enExample)
EP (3) EP1697418A2 (enExample)
JP (3) JP4991307B2 (enExample)
AT (1) ATE447587T1 (enExample)
CA (2) CA2542546A1 (enExample)
DE (1) DE602004023965D1 (enExample)
ES (1) ES2334140T3 (enExample)
WO (2) WO2005052000A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6576743B1 (en) * 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
AU2001290524A1 (en) * 2000-08-08 2002-02-18 Zymogenetics Inc. Soluble zcytor 11 cytokine receptors
DE602004028347D1 (de) * 2003-03-24 2010-09-09 Zymogenetics Inc Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
EA015706B1 (ru) * 2004-10-22 2011-10-31 Займоджинетикс, Инк. Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
WO2006086396A2 (en) * 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
US7611705B2 (en) * 2007-06-15 2009-11-03 National Cheng Kung University Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
KR20110039218A (ko) * 2008-06-30 2011-04-15 노보 노르디스크 에이/에스 항－인간 인터루킨－２０ 항체
US7837994B2 (en) * 2008-10-07 2010-11-23 National Cheng Kung University Use of anti-IL-20 antibody for treating osteoporosis
US8012478B2 (en) * 2008-10-07 2011-09-06 National Cheng Kung University Use of anti-IL-20 antibody for treating stroke
JP5860699B2 (ja) * 2008-10-07 2016-02-16 ナショナル チェン クン ユニバーシティ 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用
US8454956B2 (en) * 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
AU2011239520A1 (en) * 2010-04-16 2012-11-08 National Cheng Kung University Treating disorders associated with IL-20 receptor-mediated signaling pathway by blocking IL-20 receptor activity
US8535674B2 (en) 2010-06-15 2013-09-17 National Cheng Kung University Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
EP2812445A2 (en) 2012-02-10 2014-12-17 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
WO2013164440A1 (en) 2012-05-03 2013-11-07 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
WO2014006230A1 (en) * 2012-07-06 2014-01-09 Novo Nordisk A/S Il-20 epitopes and il-20 ligands
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies
US8603470B1 (en) * 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
EP2931356B1 (en) * 2012-12-14 2019-03-06 Mindera Corporation Methods and devices for detection and acquisition of biomarkers
US20140314741A1 (en) * 2013-04-18 2014-10-23 Developmen Center For Biotechnology Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
WO2015151057A1 (en) 2014-04-04 2015-10-08 Sabic Global Technologies B.V. Minimizing water content in ethanolamine product streams
CN106164043A (zh) 2014-04-08 2016-11-23 沙特基础工业全球技术有限公司 最小化乙醇胺产物流股中的水含量
WO2015181748A1 (en) 2014-05-27 2015-12-03 Sabic Global Technologies B.V. Production of tea 85% directly without blending with pure cut of dea 99%
US10308590B2 (en) 2014-05-30 2019-06-04 Sabic Global Technologies B.V. Quality and color of ethanolamine product streams by reduced temperature at the triethanolamine column
PL3151921T3 (pl) 2014-06-06 2020-02-28 Bristol-Myers Squibb Company Przeciwciała przeciwko receptorowi indukowanego glukokortykoidami czynnika martwicy nowotworu (gitr) i ich zastosowania
WO2016001424A2 (en) * 2014-07-03 2016-01-07 Immunoqure Ag Human-derived anti-human il-20 antibodies and assay for the identification of anti-cytokine antibodies
EP3304079B1 (en) 2015-06-03 2020-06-03 Bristol-Myers Squibb Company Anti-gitr antibodies for cancer diagnostics
MX2018006072A (es) 2015-11-19 2018-08-01 Squibb Bristol Myers Co Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos.
WO2017202813A1 (en) * 2016-05-24 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections
US9982043B2 (en) 2016-06-03 2018-05-29 National Cheng Kung University Use of IL-20 antagonists for treating pancreatic cancer
US20180057564A1 (en) * 2016-08-23 2018-03-01 Clover Biopharmaceuticals Antagonists of il-20 family of cytokines and their use
WO2018200620A1 (en) 2017-04-25 2018-11-01 National Cheng Kung University Use of il-20 antagonists for treating eye diseases
WO2018213297A1 (en) 2017-05-16 2018-11-22 Bristol-Myers Squibb Company Treatment of cancer with anti-gitr agonist antibodies
JP7258329B2 (ja) * 2018-09-01 2023-04-17 国立大学法人神戸大学 連続式振動流バッフル反応装置及び反応法
US12460009B2 (en) 2019-09-04 2025-11-04 Inserm (Institut National De La Sante Et De La Recherche Medicale) Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208021A (en) * 1987-10-05 1993-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of preparing diphtheria immunotoxins
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US20020099179A1 (en) * 1989-12-21 2002-07-25 Linda K. Jolliffe Cdr-grafted antibodies
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
GB2315386B (en) 1996-07-13 2000-10-18 Motorola Ltd Improved flow control in cellular radio networks
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
DE69637856D1 (en) 1996-08-30 2009-04-16 Human Genome Sciences Inc Interleukin-19.
DE19650541C2 (de) 1996-12-05 1999-05-12 Siemens Ag Verfahren zur Ermittlung eines ersten Referenzschriftzugs anhand mehrerer Musterschriftzüge
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6323322B1 (en) * 1997-04-30 2001-11-27 Enzon, Inc. Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
AU8571198A (en) 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6020163A (en) * 1997-08-06 2000-02-01 Zymogenetics, Inc. Lipocalin homolog
US6576743B1 (en) * 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
ES2218872T3 (es) * 1997-11-26 2004-11-16 Zymogenetics Inc Polipeptido 10 de tipo citoquina de mamifero.
EP1047781B1 (en) 1998-01-23 2004-07-28 Immunex Corporation Il-18 receptors
US6586228B1 (en) 1998-03-09 2003-07-01 Schering Corporation Polynucleotides encoding DIRS1
WO1999046379A2 (en) 1998-03-09 1999-09-16 Schering Corporation Human receptor proteins; related reagents and methods
ES2312205T3 (es) 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
WO1999061630A2 (en) 1998-05-26 1999-12-02 Regeneron Pharmaceuticals, Inc. Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
NZ510464A (en) 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
WO2000031278A1 (en) 1998-11-25 2000-06-02 Zymogenetics, Inc. Zace1: a human metalloenzyme
AU2222700A (en) 1998-12-31 2000-07-31 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
AU5047600A (en) 1999-05-27 2000-12-18 Schering Corporation Mammalian interleukin-10 homologs: il-d110 and il-d210
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2393369A1 (en) 1999-12-03 2001-06-07 Zymogenetics, Inc. Human cytokine receptor
ES2387394T3 (es) * 1999-12-23 2012-09-21 Zymogenetics, Inc. Procedimiento de tratamiento de la inflamación
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
AU2001290524A1 (en) 2000-08-08 2002-02-18 Zymogenetics Inc. Soluble zcytor 11 cytokine receptors
ATE333888T1 (de) * 2000-09-15 2006-08-15 Zymogenetics Inc Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
WO2002058724A2 (en) 2001-01-26 2002-08-01 Eli Lilly And Company Use of lp82 to treat body weight disorders
US7101539B2 (en) 2001-02-28 2006-09-05 Eli Lilly And Company Use of LP82 to treat hematopoietic disorders
JP4009535B2 (ja) 2001-03-09 2007-11-14 ザイモジェネティクス，インコーポレイティド 可溶性ヘテロダイマーサイトカイン受容体
DE10154579A1 (de) 2001-11-07 2003-05-28 Medigene Ag Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen
WO2003051384A1 (en) 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating cervical cancer
EP1546358A4 (en) 2002-03-22 2006-06-07 Zymogenetics Inc ANTI-IL-TIF ANTIBODIES AND METHOD FOR USE ON INFLAMMATION
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
JP4053444B2 (ja) * 2003-03-07 2008-02-27 シャープ株式会社 携帯可能な多機能電子機器
DE602004028347D1 (de) * 2003-03-24 2010-09-09 Zymogenetics Inc Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
EA015706B1 (ru) * 2004-10-22 2011-10-31 Займоджинетикс, Инк. Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
JP2008106946A (ja) * 2005-02-10 2008-05-08 Matsushita Electric Ind Co Ltd 冷凍サイクル装置
HUE052220T2 (hu) * 2006-09-08 2021-04-28 Abbvie Bahamas Ltd Interleukin-13 kötõfehérjék
KR20110039218A (ko) * 2008-06-30 2011-04-15 노보 노르디스크 에이/에스 항－인간 인터루킨－２０ 항체

Similar Documents

Publication Publication Date Title
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
LTPA2017040I1 (lt) Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui
EP1607404A4 (en) MONOCLONAL ANTIBODY AND HYBRIDOM THAT PRODUCES THIS
LTC2305817I2 (lt) Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas
ATE549033T1 (de) Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper
CY2012019I2 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
TW200636064A (en) Anti-respiratory syncytial virus antibodies, antigens and uses thereof
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
CY2014038I1 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
PT2311873T (pt) Anticorpo monoclonal específico para m-csf e respetivos usos
NL1027009A1 (nl) Antilichamen tegen M-CSF.
EP1448787A4 (en) HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST DENDRITIC CELLS
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
JP2007525465A5 (enExample)
JP2005516606A5 (enExample)
ITRM20040586A1 (it) Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
JP2004523538A5 (enExample)
ITRM20040105A1 (it) Anticorpo monoclonale antitenascina umana.
FI20020807A0 (fi) Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
JP2004526429A5 (enExample)
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
DK1503799T3 (da) Immunogent, monoklonalt antistof
EP1483292A4 (en) WITH BACTERIAL COLLAGE-BINDING PROTEINS CROSS-REACTIVE MONOCLONAL ANTIBODIES
WO2005047456A3 (en) Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
ITTO20010762A0 (it) Anticorpi monoclonali anti-ssrp-1 ed ibridomi producenti tali anticorpi.